A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/21 (2006.01) A61K 31/53 (2006.01) A61P 35/00 (2006.01) A61K 38/12 (2006.01)
Patent
CA 2397793
A method for treating a human patient afflicted with cancer, is provided in which therapeutically effective amounts of temozolomide and pegylated interferon alpha are administered to such a patient. Also provided is a medical kit comprising: (a) a supply of temozolomide; (b) a supply of pegylated interferon alpha; and (c) printed instructions for administering temozolomide and pegylated interferon alpha to a cancer patient.
Procédé servant à traiter un individu atteint de cancer et consistant à lui administrer des quantités efficaces sur le plan thérapeutique de témozolomide et d'alpha-interféron pégylé. Elle concerne également une trousse médicale contenant: (a) une quantité de témozolomide; (b) une quantité d'alpha-interféron pégylé; (c) des instructions imprimées servant à administrer témozolomide et alpha-interféron pégylé à un individu atteint du cancer.
Zaknoen Sara L.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Schering Corporation
LandOfFree
Combination of temozolomide and pegylated interferon-alpha... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination of temozolomide and pegylated interferon-alpha..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of temozolomide and pegylated interferon-alpha... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2084111